John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 2,725 shares at $1.86 ($5K) on 2022-07-19, disclosed to the SEC on 2022-07-19.
Scheduled sale ($5k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |